Trevisan & Cuonzo prides itself on its comprehensive understanding of the commercial context of intellectual property – both in terms of its enforcement and its commercial exploitation.
For research led pharmaceutical businesses, their IP portfolio is a crucial and important balance sheet item, to be both protected and exploited.
The firm reviews research and development contracts and licensing agreements, including from an antitrust perspective, for multiple clients in the Life Sciences sector. We are able to do this thanks to our in depth knowledge of the industry, the dynamics of innovation and patent strategies, complemented by antitrust know-how in the assessment of the competitive conformity of R&D and pharma licensing contracts.
True subject matter experts
